Recombinant CALCRL (Erenumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- CALCRL (Erenumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CALCRL (Erenumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA, Western Blotting (WB)
- Purpose
- Erenumab Biosimilar – Anti-CALCRL mAb - Research Grade
- Characteristics
- Antibody Type: IgG2-lambda
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG2 lambda
-
anti-CALCRL (Erenumab Biosimilar) antibody
Research Grade Reactivity: Human FACS Host: Human Monoclonal unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CALCRL (Erenumab Biosimilar)
- Target Type
- Biosimilar
- Background
- Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine.
- CAS-No
- 1582205-90-0
-
You are here:
